Clinical Trial Update: PET With [18F]HX4 in Head and Neck Cancer [NA]

View source ↗

Summary

This completed clinical trial evaluated PET imaging with the radiotracer [18F]HX4 in head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• [18F]HX4

Snippet

Sponsor: Maastricht Radiation Oncology | Conditions: Cancer of the Head and Neck | NA | Status: COMPLETED